RxDoctor Payments DataLook up a doctor →

Lori Wright, APRN

Gerontology · Myrtle Beach, SCNPI 1639669088

Payments from drug & device makers

$4,860in general payments, 2019–2025

Across 214 payments — averaging $22.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$365
  • E.r. Squibb & Sons, L.L.C.$355
  • Merck$336
  • Bristol Myers Squibb$259
  • AstraZeneca$235
  • GSK$196
  • plus $3K from 53 others

What the payments were for

  • Food & beverage$4,63795%
  • Education$2235%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,860 in reported general payments places this provider in the 90th percentile of 137 gerontology providers in South Carolina.

See all gerontology providers in South Carolina

Medicare billing

Part B allowed, 2024
$473,457
Medicare patients
135
Services billed
25,791

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$7,870
Anastrozole103$3,333
Ondansetron OdtOndansetron67$845
Hydroxyurea17$580
Dexamethasone29$334
Prochlorperazine Maleate15$316
Gabapentin29$288
Letrozole16$233
Lidocaine-PrilocaineLidocaine/Prilocaine14$169
Ondansetron Hcl25$157
Prednisone24$136
Doxycycline Hyclate17$92
Allopurinol11$74
Warfarin Sodium13$72
Olanzapine14$54

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$94$7,87012 claims
Lilly USA, LLCOlanzapine$167$5414 claims
Teva Pharmaceuticals USA, Inc.Acyclovir$62$5211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 137 gerontology providers in South Carolina.

Other gerontology in Myrtle Beach

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →